相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Lauren B. Rodda et al.
CELL (2021)
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
Shuai Wang et al.
CELL RESEARCH (2021)
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
Kathy Leung et al.
EUROSURVEILLANCE (2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Comparison of Four SARS-CoV-2 Neutralization Assays
Lydia Riepler et al.
VACCINES (2021)
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Qianqian Li et al.
CELL (2021)
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa et al.
CELL (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou et al.
CELL (2021)
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen et al.
CELL HOST & MICROBE (2021)
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Zhuoming Liu et al.
CELL HOST & MICROBE (2021)
The variant gambit: COVID-19's next move
Jessica A. Plante et al.
CELL HOST & MICROBE (2021)
Prevalence of SARS-CoV-2 in Karnataka, India
Manoj Mohanan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier et al.
NATURE (2021)
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Rita E. Chen et al.
NATURE MEDICINE (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Alexander Muik et al.
SCIENCE (2021)
Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India
Anup Malani et al.
LANCET GLOBAL HEALTH (2021)
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Markus Hoffmann et al.
EBIOMEDICINE (2021)
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann et al.
CELL (2021)
Antibody evasion by the P.1 strain of SARS-CoV-2
Wanwisa Dejnirattisai et al.
CELL (2021)
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
Alona Kuzmina et al.
CELL HOST & MICROBE (2021)
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
Venkata Viswanadh Edara et al.
CELL HOST & MICROBE (2021)
Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations
Binquan Luan et al.
FEBS LETTERS (2021)
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
Dan Frampton et al.
LANCET INFECTIOUS DISEASES (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Nuno R. Faria et al.
SCIENCE (2021)
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
Markus Hoffmann et al.
CELL REPORTS (2021)
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
Mark S. Graham et al.
LANCET PUBLIC HEALTH (2021)
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
Tyler N. Starr et al.
CELL REPORTS MEDICINE (2021)
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020
Sitanshu Sekhar Kar et al.
EMERGING INFECTIOUS DISEASES (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Bruno M. Tomazini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Yanchun Peng et al.
NATURE IMMUNOLOGY (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization
Hannah Kleine-Weber et al.
JOURNAL OF VIROLOGY (2019)
The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells
Constantin Brinkmann et al.
PLOS ONE (2017)
Differential Sensitivity of Bat Cells to Infection by Enveloped RNA Viruses: Coronaviruses, Paramyxoviruses, Filoviruses, and Influenza Viruses
Markus Hoffmann et al.
PLOS ONE (2013)
A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon
Marianne Berger Rentsch et al.
PLOS ONE (2011)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)